Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Cipla Limited | Pune, India | Makes it and tests it | Problems found, fixed voluntarilyMay 8, 2024 · 7 inspections |
| Ercros SA | Aranjuez, Spain | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 22, 2018 · 3 inspections, 1 with FDA action |
Recalls
- Sep 18, 2026 · Class II · Cipla USA, Inc.
Failed Impurities/Degradation Specifications
Lots: Lot#: 5KA0405, Exp 12/31/2026.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Fosfomycin: every company that makes it
- Form
- granule, for solution, oral
- Strength
- 3 g
- Approval
- ANDA ANDA211881
- On the market since
- Jan 26, 2022
- Package NDCs
69097-579-67- Official label
- DailyMed (National Library of Medicine), updated Mar 17, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?